Sensitivity to the MEK inhibitor E6201 in melanoma cells is associated with mutant BRAF and wildtype PTEN status

av Byron, Sara A, Loch, David C, Wellens, Candice L, Wortmann, Andreas, Wu, Jiayi, Wang, John, Nomoto, Kenichi, Pollock, Pamela M
Publicerad 2012

FGFR2 Point Mutations in 466 Endometrioid Endometrial Tumors: Relationship with MSI, KRAS, PIK3CA, CTNNB1 Mutations and Clinicopathological Features

av Byron, Sara A., Gartside, Michael, Powell, Matthew A., Wellens, Candice L., Gao, Feng, Mutch, David G., Goodfellow, Paul J., Pollock, Pamela M.
Publicerad 2012

Correction: FGFR2 Point Mutations in 466 Endometrioid Endometrial Tumors: Relationship with MSI, KRAS, PIK3CA, CTNNB1 Mutations and Clinicopathological Features

av Byron, Sara A., Gartside, Michael, Powell, Matthew A., Wellens, Candice L., Gao, Feng, Mutch, David G., Goodfellow, Paul J., Pollock, Pamela M.
Publicerad 2012

Loss-of-Function Fibroblast Growth Factor Receptor-2 Mutations in Melanoma

av Gartside, Michael G., Chen, Huaibin, Ibrahimi, Omar A., Byron, Sara A., Curtis, Amy V., Wellens, Candice L., Bengston, Ana, Yudt, Laura M., Eliseenkova, Anna V., Ma, Jinghong, Curtin, John A., Hyder, Pilar, Harper, Ursula L., Riedesel, Erica, Mann, Graham J., Trent, Jeffrey M., Bastian, Boris C., Meltzer, Paul S., Mohammadi, Moosa, Pollock, Pamela M.
I publikationen Mol Cancer Res (2009)